Investment Rating - The report maintains an "Accumulate" rating for the company [2] Core Views - The company is benefiting from a dual-focus strategy on clients and products, leading to strong performance in the cosmetics ODM sector [8][22] - The company has successfully transitioned to focus solely on cosmetics manufacturing, shedding its previous chemical business, which has allowed for improved operational efficiency and profitability [20][22] - The cosmetics industry is entering a high-quality recovery phase, with the company positioned to capture market share as smaller competitors exit the market [41][54] Financial Data and Profit Forecast - Total revenue projections for the company are as follows: - 2024: 1,940 million CNY - 2025: 2,218 million CNY (14.3% YoY growth) - 2026: 2,565 million CNY (15.6% YoY growth) - 2027: 2,957 million CNY (15.3% YoY growth) [7] - Net profit forecasts are: - 2025: 153 million CNY (179.7% YoY growth) - 2026: 192 million CNY (25.3% YoY growth) - 2027: 242 million CNY (26.2% YoY growth) [7] - The company’s gross margin is expected to stabilize around 17.4% for the next few years, with a notable increase in 2025 to 19.2% [7][40] Business Strategy and Market Position - The company has established itself as a leading player in the global cosmetics ODM market, with significant production capacity and a diverse client base including major international brands [8][20] - The company’s focus on high-margin products, particularly in the mask and skincare segments, is expected to drive future growth [8][10] - The company has a strong R&D team and has accumulated a significant number of patents, enhancing its competitive edge in product development [8][10] Industry Outlook - The Chinese cosmetics market is projected to continue its growth trajectory, with a compound annual growth rate of 5.84% from 2015 to 2024, positioning it as the second-largest market globally [41][47] - The industry is experiencing a consolidation phase, with leading companies gaining market share as smaller players exit, which is beneficial for the company [54][56] - Consumer demand is shifting towards high-quality and effective products, which aligns with the company’s strategic focus on innovation and quality [41][47]

Core Insights - Cosmax reported a total revenue of 2.3988 trillion KRW for the year 2025, marking a year-on-year increase of 10.7% and an operating profit of 195.8 billion KRW, up 11.6% from the previous year [2] - In Q4 2025, the company achieved revenue of 601 billion KRW, a 7.7% increase year-on-year, with an operating profit of 40.9 billion KRW, reflecting a 2.7% growth [2] - The company remains a leader in the global cosmetics contract manufacturing sector, serving major clients such as L'Oréal, Unilever, and Estée Lauder, as well as domestic brands like Huaxizi and Pechoin [2] Financial Performance - The overall performance of Cosmax is strong, with significant growth in net profit for Q4 2025; however, the operating costs increased by 12.7%, outpacing revenue growth [2] - A one-time gain of 29 billion KRW from the fair value of derivatives was recognized in Q4 2025, alongside interest expenses of 10.2 billion KRW, indicating that the apparent improvement in performance may not be as effective as it seems [3] Market Dynamics - The core markets driving growth for Cosmax are South Korea and China, with South Korea contributing over 60% of total revenue, amounting to 1.5264 trillion KRW, a 12.4% increase year-on-year [3] - The "K-BEAUTY" trend has significantly boosted sales in basic skincare products, while new categories in body care have also shown notable success [3] - The Chinese market has emerged as a second growth curve for Cosmax, with annual revenue reaching 632.7 billion KRW, reflecting a 10.2% year-on-year increase, aided by a recovery in consumer demand and expanded exports to Southeast Asia [3] Regional Performance - Southeast Asia has provided additional support, although performance varies significantly across different markets; Thailand has shown notable revenue growth, while Indonesia has experienced a decline [3] Strategic Positioning - Cosmax has successfully maintained its market position in the beauty contract manufacturing sector, but its performance has shown fluctuating growth rates, reflecting challenges and changes in the beauty market [4]

Investment Rating - The report assigns a "Buy" rating to the company with a current price of 8.70 CNY and a fair value of 10.50 CNY [2]. Core Insights - The company, Qingsong Co., Ltd., has transitioned to focus on the cosmetics ODM sector, with a significant recovery in profitability expected as operational efficiencies improve and customer orders rebound [10]. - The company has undergone a strategic shift by divesting its turpentine business and acquiring 100% of the cosmetics OEM leader, Norsbel, enhancing its competitive position in the cosmetics manufacturing industry [15][16]. - The report forecasts a positive trend in revenue and net profit, with expected net profits of 1.3 billion CNY in 2025, 1.8 billion CNY in 2026, and 2.3 billion CNY in 2027, supported by a robust customer base and product focus [10]. Summary by Sections Company Overview - Qingsong Co., Ltd. has evolved from a turpentine producer to a leading player in the cosmetics ODM market, acquiring Norsbel to strengthen its business model [15]. - The company has faced challenges due to the pandemic and regulatory pressures but is now on a recovery path with improved operational efficiency [16]. Financial Analysis - The company reported revenues of 19.69 billion CNY in 2023, with a projected slight decline to 19.40 billion CNY in 2024, followed by a recovery to 21.11 billion CNY in 2025 [9][27]. - The net profit is expected to turn positive in 2024, with significant growth projected in subsequent years, reflecting a recovery from previous losses [10][27]. Industry Analysis - The global beauty and personal care market is projected to grow to 651.6 billion USD by 2024, with a steady recovery anticipated in the cosmetics sector [43]. - The Chinese cosmetics market is expected to reach 73.7 billion USD by 2025, indicating a shift towards stable growth as the industry matures [46]. - Regulatory changes are expected to benefit compliant companies, leading to increased market concentration and the exit of non-compliant players [51]. Strategic Focus - The company is concentrating on high-value product categories, particularly facial masks, and aims to enhance its customer base by focusing on key clients [10]. - The operational strategy includes optimizing product offerings and improving supply chain efficiency, which is expected to enhance profitability and market share [10].

Investment Rating - The investment rating for the company is "Outperform" (previously "Buy") [2][8] Core Insights - The company reported a revenue of 607 million yuan for the first three quarters of 2025, representing a year-on-year increase of 28.8%. However, the net profit attributable to the parent company was 29 million yuan, a slight increase of 1.3%, while the non-recurring net profit decreased by 7.3% [5][8] - In Q3 2025, the company achieved a revenue of 236 million yuan, up 15.1% year-on-year, but the net profit decreased by 12.8% [5][8] - The company is expected to benefit from new high-quality customers starting from 2026, which will drive revenue growth [8] Financial Data and Profit Forecast - Total revenue forecast for 2025 is 924 million yuan, with a year-on-year growth rate of 32.9%. The net profit forecast for 2025 is 56 million yuan, with a growth rate of 22.8% [7][10] - The gross profit margin is projected to be 23.3% for 2025, down from 26.7% in 2024 [7][10] - The company has adjusted its profit forecast downwards due to intense industry competition and lower-than-expected Q3 profits [8] Revenue and Profitability Analysis - The company has added new "disinfection products" production capacity, enhancing its one-stop service capability, with an expected annual output of 100 million units [8] - The company is participating in the establishment of a private equity fund to explore potential acquisition targets, which may provide additional growth avenues [8] Market Comparison - The company's market capitalization as of October 28, 2025, corresponds to a PE ratio of 35 for 2025, 26 for 2026, and 21 for 2027, compared to a comparable company PE average of 28 for 2026 [8]

Core Viewpoint - Qingsong Co. reported a significant turnaround in its financial performance for the first three quarters of 2025, achieving a revenue of 1.553 billion yuan, a year-on-year increase of 12%, and a net profit of 111 million yuan, reflecting a substantial growth of 246.98% [1][2][4]. Financial Performance - The revenue for Qingsong Co. in the first three quarters of 2025 was 1.553 billion yuan, compared to 1.387 billion yuan in the same period of 2024, marking a 12% increase [3][5]. - The net profit reached 111 million yuan, a significant increase from 31.92 million yuan in the previous year, indicating a growth rate of 246.98% [3][4]. - This is the first time in five years that Qingsong Co. has achieved a "double increase" in both revenue and net profit for the first three quarters [5][6]. Operational Efficiency - The company has shown improved operational efficiency, as evidenced by the significant increase in net profit compared to revenue growth, indicating enhanced profitability [1][5]. - Qingsong Co. reported a net cash flow from operating activities of 139 million yuan, a year-on-year increase of 50.11%, demonstrating improved cash recovery capabilities [5][10]. Asset Management - Qingsong Co. successfully disposed of a 148-acre industrial park project, generating a cash inflow of 163 million yuan, which contributed approximately 31.25 million yuan to the net profit for the first three quarters [6][10]. - The disposal of this asset has improved the company's cash flow and reduced future capital expenditure pressures, allowing it to focus more on its core cosmetics business [10][11]. Strategic Focus - The company’s subsidiary, Norsbel, has maintained a strong market position, achieving double-digit revenue growth despite a challenging macroeconomic environment [5][12]. - Norsbel's strategy emphasizes focusing on core customers and high-value products, which has led to a 16.04% increase in R&D expenses, outpacing revenue growth [12][14]. - Qingsong Co. aims to enhance its core competitiveness in the cosmetics sector through continuous improvements in product development, market expansion, cost control, and structural optimization [12][16].

Fixed Income - The Campisi model dissects bond fund returns into four dimensions: income effect, government bond effect, spread effect, and selection effect, providing a systematic analysis of return sources [2][7][10] - The model's core advantage lies in high-frequency tracking and dynamic adaptability, capturing strategy adjustments and market changes [8][10] - Empirical data shows that top-performing bond funds in 2025 exhibit high duration exposure and convexity premium capabilities, while quality "fixed income+" funds enhance returns through dynamic adaptability of convertible bonds and equity factors [2][10] Non-Bank Financial Sector - The non-bank financial sector has underperformed compared to the overall equity market, with a year-to-date increase of 10.6% as of October 14, 2025, compared to 23.5% for the Wind All A Index [11][12] - Strong Q3 earnings expectations are anticipated to drive valuation growth, with significant increases in equity holdings for major insurers like China Life and Ping An, contributing positively to their investment income [12][13] - The sector may benefit from a shift in market preference towards lower valuation industries, with potential for improved performance in Q3 2025 [14][15] Health Insurance - The recent guidelines from the National Financial Regulatory Administration support the development of dividend-type long-term health insurance, which may lower actual costs for policyholders and encourage product innovation among insurers [3][16][17] - The health insurance market has seen a decline in new business value, but the new policies may stimulate sales through reduced prices and innovative product offerings [16][17] Beauty Industry - The Chinese cosmetics market is projected to reach 579.1 billion yuan in 2025, growing at a rate of 6.1%, with the contract manufacturing sector also expanding significantly [5][19] - Bawei Co., Ltd. has established a strong market presence and is implementing a "big client, big product" strategy, focusing on customized production and digital supply chain management [20][22] - The company reported a revenue of 371 million yuan in H1 2025, reflecting a year-on-year increase of 39.3%, and aims to enhance its market share through participation in international exhibitions and investment in high-growth sectors [20][22]

Core Viewpoint - The company reported significant growth in its packaging and printing business in the first half of the year, while the cosmetics segment's revenue share did not increase further, and gross margins remained stable [1] Group 1: Business Performance - The packaging and printing business experienced substantial year-on-year revenue growth [1] - The cosmetics business's contribution to total revenue did not see further improvement [1] - Gross margin levels were maintained without significant fluctuations [1] Group 2: Strategic Initiatives - The company is enhancing its cosmetics OEM business by executing a defined business development strategy and focusing on building strategic partnerships with key clients, particularly ODM customers [1] - A rolling forecast system and real-time order shipment monitoring system were established to improve business precision and service quality [1] Group 3: Product Development - The company has identified key product development strategies based on market research and competitive analysis, focusing on skincare, wax-based, and powder categories [1] - New flagship products such as water light cream, multi-use potato mud cream, and blush cream were successfully developed [1] Group 4: Operational Strategy - The company's main operational focus is on the principles of "increasing revenue" and "cost-saving" to achieve continuous business expansion and profit improvement [1]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The full implementation of the cosmetic safety assessment system is expected to enhance the company's market share [1] - The new assessment system increases the product registration cycle and costs, which may accelerate industry consolidation [7] - The company is proactively establishing testing centers and enhancing raw material R&D to strengthen its supply chain [7] - The company is expected to see significant growth in revenue and net profit over the next few years, with projected net profits of 69 million, 91 million, and 115 million for 2025, 2026, and 2027 respectively [6][11] Financial Data and Profit Forecast - Total revenue is projected to grow from 1,009 million in 2025 to 1,230 million in 2027, with a compound annual growth rate (CAGR) of approximately 7.4% [6][11] - The net profit attributable to the parent company is expected to increase from 69 million in 2025 to 115 million in 2027, reflecting a growth rate of 26.8% in 2027 [6][11] - The company's earnings per share (EPS) is forecasted to rise from 0.62 in 2025 to 1.03 in 2027 [6][11] - The projected price-to-earnings (PE) ratios for 2025, 2026, and 2027 are 31, 24, and 19 respectively [7] Industry Context - The full safety assessment system, implemented on May 1, 2025, has led to a significant decline in the number of cosmetic registrations, with a 30.5% decrease in ordinary cosmetic filings and a 46.7% drop in special cosmetic registrations from May to July 2025 [4] - The new assessment requirements are expected to raise the bar for contract manufacturers in terms of raw material management, R&D capabilities, and supply chain collaboration [7]

Investment Rating - The report maintains a "Buy" rating for the company [2] Core Views - The company achieved a revenue of 695 million yuan in 2024, representing a year-on-year growth of 48.3%, and a net profit of 45 million yuan, up 10.3% year-on-year, which met expectations [7] - The company plans to distribute a cash dividend of 3.0 yuan per share (including tax) for 2024, with a distribution ratio of 56.71% [7] - In Q1 2025, the company reported a revenue of 162 million yuan, a year-on-year increase of 40.1%, and a net profit of 9 million yuan, up 8.8% year-on-year, slightly below expectations [7] - The company is focusing on a major client strategy and has formed partnerships with emerging brands to drive revenue growth, with domestic revenue reaching 642 million yuan in 2024, a 40.5% increase [7] - The company is enhancing its raw material research and investment to improve integrated capabilities and increase the value-added of its OEM services [7] - The profit forecast for 2025-2027 has been adjusted downwards, with expected net profits of 69 million yuan, 91 million yuan, and 115 million yuan respectively [7] Financial Data and Profit Forecast - Total revenue is projected to reach 1,009 million yuan in 2025, with a year-on-year growth rate of 45.2% [6] - The gross profit margin is expected to be 26.4% in 2025, with a net profit margin of 6.5% [6] - The company’s return on equity (ROE) is forecasted to be 15.6% in 2025 [6] - The earnings per share (EPS) is projected to be 0.81 yuan in 2025 [6]